2018
DOI: 10.3205/dgkh000313
|View full text |Cite
|
Sign up to set email alerts
|

The rates of quinolone, trimethoprim/sulfamethoxazole and aminoglycoside resistance among Enterobacteriaceae isolated from urinary tract infections in Azerbaijan, Iran

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 27 publications
1
2
0
Order By: Relevance
“…However, the emergence of high levels of resistance of uropathogenic E. coli against trimethoprim/sulfamethoxazole has been reported in both developing countries (54 -82%) and developed countries (14.6 -37.1%) (28)(29)(30). The present study also discovered an elevated resistance rate to trimethoprim/sulfamethoxazole (54.1%), which is in accordance with other Iranian studies (19,24,31). According to these results, trimethoprim-sulfamethoxazole should no longer be used as the primary empirical treatment in Iran.…”
Section: Discussionsupporting
confidence: 92%
“…However, the emergence of high levels of resistance of uropathogenic E. coli against trimethoprim/sulfamethoxazole has been reported in both developing countries (54 -82%) and developed countries (14.6 -37.1%) (28)(29)(30). The present study also discovered an elevated resistance rate to trimethoprim/sulfamethoxazole (54.1%), which is in accordance with other Iranian studies (19,24,31). According to these results, trimethoprim-sulfamethoxazole should no longer be used as the primary empirical treatment in Iran.…”
Section: Discussionsupporting
confidence: 92%
“…Quinolone antimicrobial resistance can be conveyed by other plasmid resistance genes that can codify for a mutant aminoglycoside modifying enzyme (AME), thus conferring resistance to both of the antimicrobial classes simultaneously [ 6 , 8 ]. Several studies have evaluated the simultaneous presence of quinolone resistance and aminoglycoside resistance in Enterobacteriaceae , particularly, against amikacin [ 9 , 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…Higher rates have been described in other studies. In Iran the resistance rate was 47.9% for tobramycin, 39.3% for kanamycin, and 27.8% for gentamicin (Yekani et al, 2018) and in India the rate was 31% for all aminoglycosides (Mardourian et al, 2023). In Nigeria, the study conducted among pediatric population found 96.9% of resistance to kanamycin (Oli et al, 2019).…”
Section: Discussionmentioning
confidence: 97%